Clinical trials
Active, not recruiting Phase 2 Head and Neck Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ALX Oncology Inc. | 2 |
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| Washington University School of Medicine | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Alain Algazi | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Aveta Biomics, Inc. | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Head and Neck Neoplasms | 37 |
| Squamous Cell Carcinoma of Head and Neck | 18 |
| Carcinoma, Squamous Cell | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Oropharyngeal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Mouth Neoplasms | 3 |
| Salivary Gland Neoplasms | 3 |
| Carcinoma | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.